TLX insider transaction filings

Name: TLX insider transaction filings (SEC Form 4)
Creator: FilingPulse
License: https://www.sec.gov/edgar

Telix Pharmaceuticals Ltd — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-06. Screen TLX transaction legs live →

Filed	Form	Insider	Reported transactions	Source
2026-05-06	4	Behrenbruch Christian — MD & Group CEO, Director	Purchase (P): 34,500 @ $14.48 · Purchase (P): 33,435 @ $14.87	EDGAR
2026-04-01	4	Smith Darren Charlton — Group Chief Financial Officer	Option exercise (M): 1,111 @ $0 · Option exercise (M): 1,111 (derivative) @ $0	EDGAR

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TLX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →